Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 4.78TCr 715.71Cr 651.87Cr 600.66Cr 546.38Cr 1.03TCr 66TCr 1.08TCr 7.31TCr 2.91TCr 36TCr 2.69TCr 2.63TCr 1,13600Cr P/E 2026 *
37.1x
P/E 2027 * 27.7x
Enterprise Value 4.4TCr 658.99Cr 600.21Cr 553.06Cr 503.08Cr 943.8Cr 61TCr 991.92Cr 6.73TCr 2.68TCr 33TCr 2.47TCr 2.42TCr 1,04600Cr EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.54x
Free-Float
62.23%
Yield 2026 *
0.97%
Yield 2027 * 1.35%
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 740.49Cr
-0.30%-5.62%+28.35%+127.66% 1,20400Cr
+1.25%-4.60%+33.56%+80.57% 64TCr
+0.94%-2.80%+22.88%+106.94% 50TCr
-0.60%-2.39%+27.92%+67.00% 38TCr
+0.69%-9.00%+40.68%+31.42% 33TCr
+0.41%-4.81%+24.99%+51.91% 28TCr
+0.81%-3.72%-1.35%+30.72% 27TCr
-0.15%-6.73%+27.23%+64.15% 24TCr
-0.06%-0.91%+29.95%+120.58% 21TCr
Average +0.65%-4.39%+26.02%+75.66% 45TCr
Weighted average by Cap. +0.62%-4.71%+27.25%+88.32%

Financials

2026 *2027 *
Net sales 808.66Cr 121.14Cr 110.34Cr 101.67Cr 92Cr 173.5Cr 11TCr 182.35Cr 1.24TCr 491.81Cr 6.13TCr 454.53Cr 444.95Cr 19TCr 982.62Cr 147.2Cr 134.07Cr 123.54Cr 112.38Cr 210.82Cr 14TCr 221.57Cr 1.5TCr 597.61Cr 7.45TCr 552.31Cr 540.67Cr 23TCr
Net income 132.49Cr 20Cr 18Cr 17Cr 15Cr 28Cr 1.84TCr 30Cr 202.74Cr 81Cr 1TCr 74Cr 73Cr 3.15TCr 177.89Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.47TCr 40Cr 272.2Cr 108.19Cr 1.35TCr 100Cr 98Cr 4.23TCr
Net Debt -378.61Cr -57Cr -52Cr -48Cr -43Cr -81Cr -5.25TCr -85Cr -579.34Cr -230.26Cr -2.87TCr -212.81Cr -208.32Cr -9TCr -284.26Cr -43Cr -39Cr -36Cr -33Cr -61Cr -3.94TCr -64Cr -434.98Cr -172.88Cr -2.15TCr -159.78Cr -156.41Cr -6.76TCr
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Asymchem Laboratories (Tianjin) Co., Ltd.